Colección SciELO Chile

Departamento Gestión de Conocimiento, Monitoreo y Prospección
Consultas o comentarios: productividad@anid.cl
Búsqueda Publicación
Búsqueda por Tema Título, Abstract y Keywords



L-Arginine Enhances Intracellular Killing of Carbapenem-Resistant <i>Klebsiella pneumoniae</i> ST258 by Murine Neutrophils
Indexado
WoS WOS:000592429700001
Scopus SCOPUS_ID:85096758839
DOI 10.3389/FCIMB.2020.571771
Año 2020
Tipo artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras


Abstract



Carbapenem-resistant Klebsiella pneumoniae ST258 (CRKP-ST258) are a global concern due to their rapid dissemination, high lethality, antibiotic resistance and resistance to components of the immune response, such as neutrophils. Neutrophils are major host mediators, able to kill well-studied and antibiotic-sensitive laboratory reference strains of K. pneumoniae. However, CRKP-ST258 are able to evade neutrophil phagocytic killing, persisting longer in the host despite robust neutrophil recruitment. Here, we show that neutrophils are unable to clear a CRKP-ST258 isolate (KP35). Compared to the response elicited by a prototypic K. pneumoniae ATCC 43816 (KPPR1), the neutrophil intracellular response against KP35 is characterized by equivalent production of reactive oxygen species (ROS) and myeloperoxidase content, but impaired phagosomal acidification. Our results ruled out that this phenomenon is due to a phagocytosis defect, as we observed similar efficiency of phagocytosis by neutrophils infected with KP35 or KPPR1. Genomic analysis of the cps loci of KPPR1 and KP35 suggest that the capsule composition of KP35 explain the high phagocytosis efficiency by neutrophils. Consistent with other reports, we show that KP35 did not induce DNA release by neutrophils and KPPR1 only induced it at 3 h, when most of the bacteria have already been cleared. l-arginine metabolism has been identified as an important modulator of the host immune response and positively regulate T cells, macrophages and neutrophils in response to microbes. Our data show that l-arginine supplementation improved phagosome acidification, increased ROS production and enhanced nitric oxide consumption by neutrophils in response to KP35. The enhanced intracellular response observed after l-arginine supplementation ultimately improved KP35 clearance in vitro. KP35 was able to dysregulate the intracellular microbicidal machinery of neutrophils to survive in the intracellular environment. This process, however, can be reversed after l-arginine supplementation.

Métricas Externas



PlumX Altmetric Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Disciplinas de Investigación



WOS
Immunology
Microbiology
Scopus
Sin Disciplinas
SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional



Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.


Autores - Afiliación



Ord. Autor Género Institución - País
1 Penaloza, Hernan F. Hombre Pontificia Universidad Católica de Chile - Chile
Univ Pittsburgh - Estados Unidos
University of Pittsburgh - Estados Unidos
University of Pittsburgh School of Medicine - Estados Unidos
2 Ahn, Danielle Mujer Columbia Univ - Estados Unidos
Columbia University Irving Medical Center - Estados Unidos
3 SCHULTZ-LOMBARDIC, BARBARA MELINKA Mujer Pontificia Universidad Católica de Chile - Chile
4 Pina-Iturbe, Alejandro Hombre Pontificia Universidad Católica de Chile - Chile
5 González, Liliana A. Mujer Pontificia Universidad Católica de Chile - Chile
6 BUENO-RAMIREZ, SUSAN MARCELA Mujer Pontificia Universidad Católica de Chile - Chile

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento



Fuente
NIH
Fondo Nacional de Desarrollo Científico y Tecnológico de Chile
Fondo Nacional de Desarrollo Científico y Tecnológico
National Institutes of Health
Instituto Milenio en Inmunología e Inmunoterapia
Comisión Nacional de Investigación Científica y Tecnológica de Chile
National Heart, Lung, and Blood Institute
Millennium Institute on Immunology and Immunotherapy

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos



Agradecimiento
This study was supported by grants from Fondo Nacional de Desarrollo Cientifico y Tecnologico de Chile (grant no. 1170964), the Millennium Institute on Immunology and Immunotherapy (ICN09_016), the Comision Nacional de Investigacion Cientifica y Tecnologica de Chile (grant no. 21140214), and NIH K08 HL138289.
This study was supported by grants from Fondo Nacional de Desarrollo Cientı́fico y Tecnológico de Chile (grant no. 1170964), the Millennium Institute on Immunology and

Muestra la fuente de financiamiento declarada en la publicación.